Zhejiang Provincial People's Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1978-01-01
- Employees
- -
- Market Cap
- -
Efficacy and Safety of Telitacicept Combined With Tofacitinib for Refractory Rheumatoid Arthritis
Recruiting
- Conditions
- TelitaciceptTreatment ComplianceRheumatoid Arthritis
- First Posted Date
- 2025-05-18
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06979271
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)
Not Applicable
Not yet recruiting
- Conditions
- Triple-Negative Breast Cancer (TNBC)Neoadjuvant ChemotherapyChemotherapy Effects
- Interventions
- Drug: nab-paclitaxel, carboplatin, and bemotuzumabDrug: epirubicin, cyclophosphamide, and bemotuzumab
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 55
- Registration Number
- NCT06975644
Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence
Not yet recruiting
- Conditions
- Glioblastoma Multiforme (GBM)
- First Posted Date
- 2025-04-22
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06939400
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Drug-induced Kidney Injury Model
Recruiting
- Conditions
- Acute Kidney Injury
- First Posted Date
- 2025-04-22
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 1500
- Registration Number
- NCT06939387
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer
- First Posted Date
- 2025-03-24
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06890858
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (Ⅰ) Versus Metformin Tablets in Patients with New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study
Phase 4
Not yet recruiting
- Conditions
- New-onset Type 2 Diabetes
- Interventions
- Drug: henagliflozin proline and metformin hydrochloride extended-release tablets (Ⅰ)
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 268
- Registration Number
- NCT06888050
Clinical Study of NKG2D CAR-NK Combined with PD-1 Monoclonal Antibody in the Treatment of ATC
Phase 1
Not yet recruiting
- Conditions
- Anaplastic Throid Carcinoma
- Interventions
- Drug: NKG2D CAR-NK with PD-1 Antibody
- First Posted Date
- 2025-03-04
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT06856278
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
An Exploratory Study to Confirm Efficacy of Modified Deep Cervical Lymphovenous Anastomosis (LVA) in Alzheimer's Disease/ Parkinson's Disease
Not Applicable
Recruiting
- Conditions
- Alzheimer DiseaseParkinson Disease
- First Posted Date
- 2025-02-28
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 160
- Registration Number
- NCT06852352
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
Impact of Thyroid Treatment on Ovarian Function and Pregnancy Outcomes in Women with Differentiated Thyroid Cancer
Not Applicable
Not yet recruiting
- Conditions
- Thyroid Gland
- First Posted Date
- 2025-02-25
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06845098
- Locations
- 🇨🇳
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China
The Temporally Interfering in Patients with Disorders of Consciousness
Not Applicable
Not yet recruiting
- Conditions
- Disorders of Consciousness
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Zhejiang Provincial People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06822192
© Copyright 2025. All Rights Reserved by MedPath